Vālenz® Promotes Maurice Steenland as Chief Product Officer
PHOENIX, Ariz. (Aug. 5, 2022) — Vālenz® is pleased to announce Maurice Steenland has been promoted to Chief Product Officer.
Leading innovation and investment strategy for the Vālenz® Healthcare Ecosystem Optimization Platform, Steenland is highly engaged in synchronizing departments to accelerate strategic initiatives that bring greater value to clients. Steenland also offers deep expertise in uncovering operational efficiencies and engaging data and analytics to enable better decisions.
“With 20+ years of senior leadership experience at leading healthcare organizations, Maurice is our catalyst for ecosystem innovation and scale,” said Rob Gelb, Chief Executive Officer of Valenz. “Through a highly strategic and data-driven approach, he leads our investment strategy, uncovering new solutions to deliver a powerful data platform that enables more proactive decision-making and identifies opportunities to boost plan performance for our customers.”
“A firm believer in the company culture of one, Maurice inspires us every day to engage early and often to deliver smarter, better, faster healthcare,” Gelb added.
Steenland also has held leadership positions at CIGNA Healthcare, Coventry Health Care and Intracorp, with specialization in operations, utilization management, strategy, and business development. He earned his master’s in business administration from the prestigious Wharton School of the University of Pennsylvania.
Vālenz® simplifies the complexities of self-insurance by offering an end-to-end Healthcare Ecosystem Optimization Platform that manages the cost and quality of care for employers and their members. To balance the relationship between healthcare quality, advocacy and cost, the Valenz enterprise-level solution suite aligns the member, provider and payer. Supported by a dynamic, innovation-first culture and a steadfast commitment to data transparency and decision enablement, Valenz leverages its technology infrastructure and enterprise data warehouse to drive value across clinical and member advocacy, network development and the validation, integrity and accuracy (VIA) of claims. Learn more about how Valenz engages early and often for smarter, better, faster healthcare. Valenz is backed by Great Point Partners.